Prof. ALİ NUR TURGUT ULUTİN

Publication Network

Articles 128

1. Clinical significance and expression profile of DNA repair-associated miR-34c-5p and miR-1246 in prostate malignancy

Habibi S., Rouhi V., Koseoglu H., Ari E., ULUTİN A. N. T., GÜVEN M.

Human Gene , vol.48, 2026 (ESCI, Scopus)

2. Biomarkers of Endothelial Dysfunction in Cerebral Small Vessel Disease

Tanriverdi U., GÜREL Ç., Ayaz G., ULUTİN A. N. T., Arslan S., KIZILKILIÇ O., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.63, pp.1-8, 2026 (SCI-Expanded, Scopus, TRDizin)

3. Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.

Sordu P., Alaylıoğlu M., Samancı B., Bulu E., Güleç Z. E. K., Bilgiç B., et al.

Journal of Alzheimer's disease : JAD , vol.105, pp.481-493, 2025 (SCI-Expanded, Scopus)

4. Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease

Ayaz G., SORDU DELİBALTA P., KÜÇÜKSEZER U. C., HANAĞASI H. A., ALAYLIOĞLU M., GÜRVİT İ. H., et al.

JOURNAL OF ALZHEIMERS DISEASE , vol.105, no.1, pp.172-185, 2025 (SCI-Expanded, Scopus)

5. Mitochondrial Common Deletion Level in Adipose Tissue is Not Associated with Obesity but is Associated with a Structural Change in Triglycerides as Revealed by FTIR Spectroscopy

Yilmaz A., BAHTİYAR N., Mollaoglu A. D., Zengin K., TAŞKIN H. E., Karimova A., et al.

MEDICAL PRINCIPLES AND PRACTICE , vol.33, pp.74-82, 2024 (SCI-Expanded, Scopus)

6. Combined resveratrol and vitamin D treatment ameliorate inflammation-related liver fibrosis, ER stress, and apoptosis in a high-fructose diet/streptozotocin-induced T2DM model

Anapali M., Kaya-Dagistanli F., Akdemir A. S., Aydemir D., Ulusu N. N., Ulutin T., et al.

HISTOCHEMISTRY AND CELL BIOLOGY , vol.158, no.3, pp.279-296, 2022 (SCI-Expanded, Scopus) Sustainable Development

7. Effect of vitamin D supplementation on OPG/RANKL signalling activities in endothelial tissue damage in diet-induced diabetic rat model

Celebi G., Anapali M., Dagistanli F. K., Akdemir A. S., Aydemir D., Ulusu N. N., et al.

PHARMACOLOGICAL REPORTS , vol.74, no.1, pp.124-134, 2022 (SCI-Expanded, Scopus) Sustainable Development

8. Topical application of metformin accelerates cutaneous wound healing in streptozotocin-induced diabetic rats

Tombultürk F. K., Todurga-Seven Z. G., Huseyinbas O., Özyazgan S., Ulutin T., Kanigur-Sultuybek G.

MOLECULAR BIOLOGY REPORTS , vol.49, no.1, pp.73-83, 2022 (SCI-Expanded, Scopus) Sustainable Development

9. CIRCULATING BIOMARKERS OF ENDOTHELIAL DYSFUNCTION IN CEREBRAL SMALL VESSEL DISEASE

Tanriverdi U., GÜREL Ç., Ayaz G., Ulutin T., ARSLAN M. S., KIZILKILIÇ O., et al.

INTERNATIONAL JOURNAL OF STROKE , vol.16, no.2_SUPPL, pp.41, 2021 (SCI-Expanded, Scopus)

10. Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity.

Yenmis G., Yaprak Sarac E., Besli N., Soydas T., Tastan C., Dilek Kancagi D., et al.

Acta histochemica , vol.123, pp.151709, 2021 (SCI-Expanded, AHCI, Scopus) Sustainable Development

11. Coronary Artery Disease Severity and Platelet Aggregation

Ayaz G., KARADAĞ B., GÜVEN M., SULTUYBEK G. K., DİRİCAN A., Ilerigelen B., et al.

Sabiad , vol.4, no.1, pp.13-19, 2021 (Peer-Reviewed Journal)

12. Statik Manyetik Alanın Trombosit Agregasyonuna Etkisi

Gürel Ç., Ayaz G., Tuncel H., Kalkan T., Kurşun N., Ulutin A. N. T.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi (SABİAD) , vol.3, no.3, pp.173-178, 2020 (Peer-Reviewed Journal)

13. Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease

Gezen-Ak D., Alaylıoğlu M., Genç G., Şengül B., Keskin E., Sordu P., et al.

JOURNAL OF ALZHEIMERS DISEASE , no.1, pp.287-307, 2020 (SCI-Expanded, Scopus)

14. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma

Klna I., Sultuybek G. K., Soydas T., Yenmis G., BİÇEROĞLU H., Dirican A., et al.

BRITISH JOURNAL OF NEUROSURGERY , vol.33, no.2, pp.165-170, 2019 (SCI-Expanded, Scopus) Sustainable Development

15. Increased mitochondrial common deletion in platelets from patients with type 2 diabetes is not associated with abnormal platelet activity or mitochondrial function.

Karimova A., HACIOGLU Y., Bahtiyar N., Niyazoglu M., AKBAŞ F., Yilmaz E., et al.

Molecular medicine reports , vol.18, no.3, pp.3529-3536, 2018 (SCI-Expanded, Scopus) Sustainable Development

16. Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.

Ekizoglu S., Seven D., Ulutin T., Guliyev J., Buyru N.

BMC cancer , vol.18, pp.477, 2018 (SCI-Expanded, Scopus)

17. PRR4: A novel downregulated gene in laryngeal cancer

Ekizoglu S., Ulutin T., Guliyev J., Buyru N.

Oncology Letters , vol.15, no.4, pp.4669-4675, 2018 (SCI-Expanded, Scopus) Sustainable Development

18. Genetic variants rs1994016 and rs3825807 in ADAMTS7 affect its mRNA expression in atherosclerotic occlusive peripheral arterial disease

Bayoglu B., Arslan C., Tel Ç., Ulutin T., Dirican A., Deser S. B., et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.32, no.1, 2018 (SCI-Expanded, Scopus)

19. Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia?

Gungor Z. B., Ekmekci H., Tuten A., Toprak S., Ayaz G., Caliskan O., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.296, no.3, pp.495-502, 2017 (SCI-Expanded, Scopus)

20. Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome.

Sipahioglu N. T., Ilerigelen B., Gungor Z. B., Ayaz G., Ekmekci H., Gurel Ç., et al.

Chinese medical journal , vol.130, pp.1564-1569, 2017 (SCI-Expanded, Scopus)

21. ENDOTHELIAL DYSFUNCTION MARKERS IN LOW CARDIOVASCULAR RISK INDIVIDUALS: COMPARISON OF MALES AND FEMALES

Gungor Z. B., Sipahioglu N., Sonmez H., Ekmekci H., Toprak S., Ayaz G., et al.

JOURNAL OF MEDICAL BIOCHEMISTRY , vol.36, pp.62-72, 2017 (SCI-Expanded, Scopus)

22. Glia derived neurotrophic factor: Its regulation by vitamin D and possible relation to neurodegeneration

ULUTİN A. N. T., GEZEN AK D., DURSUN E., YıLMAZER S.

BİOCHEMISTRY ANALYTICAL BIOCHEMISTRY , vol.5, no.3, pp.48, 2016 (Peer-Reviewed Journal)

23. CT120A Acts as an Oncogene in Head and Neck Squamous Cell Carcinoma.

BALTACI E., Ekizoglu S., SARI E., KARAMAN E., Ulutin T., Buyru N.

Journal of Cancer , vol.6, pp.1255-9, 2015 (SCI-Expanded, Scopus)

24. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.

Dursun E., Gezen-Ak D., Hanagasi H., Bilgic B., Lohmann E., Ertan S., et al.

Journal of neuroimmunology , vol.283, pp.50-7, 2015 (SCI-Expanded, Scopus)

25. DLEC1 is not silenced solely by promoter methylation in head and neck squamous cell carcinoma

Seven D., Yavuz E., Kilic E., Baltaci E., Karaman E., Ulutin T., et al.

GENE , vol.563, no.1, pp.83-86, 2015 (SCI-Expanded, Scopus) Sustainable Development

26. The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population

Ayaz G., Batar B., Kanigur G., Guven M., Onaran I., Karadag B., et al.

GENE , vol.527, no.1, pp.301-305, 2013 (SCI-Expanded, Scopus)

27. LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer

Tigli H., Seven D., Tunc M., Sanli O., BASARAN S., Ulutin T., et al.

MOLECULAR CARCINOGENESIS , vol.52, no.8, pp.660-665, 2013 (SCI-Expanded, Scopus) Sustainable Development

28. Vitamin D Receptor Gene Haplotype Is Associated with Late-Onset Alzheimer's Disease

Gezen-Ak D., Dursun E., Bilgic B., Hanagasi H., Ertan T., Gurvit H., et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , vol.228, no.3, pp.189-196, 2012 (SCI-Expanded, Scopus) Sustainable Development

29. Association of MDR-1 gene polymorphism and plasma platelet activating factor levels in patients with coronary artery disease

ULUTİN T., Ayaz G., KARADAĞ B., KANIGÜR G., GÜVEN M., ONARAN İ., et al.

THROMBOSIS RESEARCH , vol.130, no.1, pp.130-131, 2012 (SCI-Expanded, Scopus)

30. The L858R mutation of the EGFR gene might be associated with smoking in non-small cell lung cancer

Buyru N., Baykara O., Tansarikaya M., Ulutin T.

CANCER RESEARCH , vol.71, 2011 (SCI-Expanded, Scopus) Sustainable Development

31. Expression of EMSY gene in sporadic ovarian cancer

Altinisik J., KARATEKE A., COKSUER H., Ulutin T., Buyru N.

MOLECULAR BIOLOGY REPORTS , vol.38, no.1, pp.359-363, 2011 (SCI-Expanded, Scopus) Sustainable Development

32. Genetic Alterations of the LKB1 Gene in Head and Neck Cancer

Kenanli E., Karaman E., Enver O., Ulutin T., Buyru N.

DNA AND CELL BIOLOGY , vol.29, no.12, pp.735-738, 2010 (SCI-Expanded, Scopus) Sustainable Development

33. 5. Genetic alterations of the LKB1 gene in head and neck cancer.

ULUTİN T.

DNA Cell Biol. , vol.29, no.12, pp.735-738, 2010 (SCI-Expanded) Sustainable Development

34. Expression of EMSY gene in sporadic ovarian cancer

ULUTİN T.

MOLECULAR BIOLOGY REPORTS , vol.38, no.1, pp.359-363, 2010 (SCI-Expanded, Scopus) Sustainable Development

35. Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer

Altinisik J., Balta Z. B., Aydin G., Ulutin T., Buyru N.

MOLECULAR BIOLOGY REPORTS , vol.37, no.1, pp.263-267, 2010 (SCI-Expanded, Scopus) Sustainable Development

36. Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension.

Ekmekci H. A., Ekmekci O. B., Erdine S., Soenmez H. A., Ataev Y., Oeztuerk Z. B., et al.

Journal of thrombosis and thrombolysis , vol.28, no.4, pp.418-24, 2009 (SCI-Expanded, Scopus)

37. Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer.

ULUTİN T.

Mol Biol Rep. , vol.37, no.1, pp.263-267, 2009 (SCI-Expanded) Sustainable Development

38. Relationship between two estrogen receptor-alpha gene polymorphisms and angiographic coronary artery disease

Karadag B., Guven M., Hacıoğlu Y., Oz E., Batar B., Domanic N., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.9, no.4, pp.267-272, 2009 (SCI-Expanded, Scopus, TRDizin)

39. Relationship between two estrogen receptor-alpha gene polymorphisms and angiographic coronary artery disease.

ULUTİN T.

Anadolu Kardiyol ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , vol.9, no.4, pp.267-272, 2009 (SCI-Expanded)

40. Toxic-dose warfarin-induced apoptosis and its enhancement by gamma ionizing radiation in leukemia K562 and HL-60 cells is not mediated by induction of oxidative stress

Onaran I., Sencan S., Demirtas H., Aydemir B., Ulutin T., Okutan M.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.378, no.5, pp.471-481, 2008 (SCI-Expanded, Scopus) Sustainable Development

41. Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension.

ULUTİN T.

J Thromb JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.28, no.4, pp.418-424, 2008 (SCI-Expanded)

42. Factor V Leiden, prothrombin G20210A and protein C mutation frequency in Turkish venous thrombosis patients

Altinisik J., Ates O., Ulutin T., Cengiz M., Buyru N.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.14, no.4, pp.415-420, 2008 (SCI-Expanded, Scopus)

43. VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients

Ozgon G. O., Langaee T. Y., feng h., Buyru N., Ulutin T., Hatemi A. C., et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.64, no.9, pp.889-894, 2008 (SCI-Expanded, Scopus)

44. VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.

ULUTİN T.

Eur J Clin Pharmacol. , vol.64, no.9, pp.889-894, 2008 (SCI-Expanded)

45. Toxic-dose warfarin-induced apoptosis and its enhancement by gamma ionizing radiation in leukemia K562 and HL-60 cells is not mediated by induction of oxidative stress.

ULUTİN T.

Naunyn Schmiedebergs Arch Pharmacol. , vol.378, no.5, pp.471-481, 2008 (SCI-Expanded)

46. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.

ULUTİN T.

Clin Appl Thromb Hemost. , vol.14, no.4, pp.415-420, 2007 (SCI-Expanded)

47. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency

Guven M., Guven G. S., Öz E., Ozaydin A., Batar B., Ulutin T., et al.

HEART AND VESSELS , vol.22, pp.355-360, 2007 (SCI-Expanded, Scopus)

48. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency.

ULUTİN T.

Heart Vessels. , vol.22, no.6, pp.355-360, 2007 (SCI-Expanded)

49. Molecular analysis of factor v leiden, factor v Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and a 1298C mutations related to Turkish thrombosis patients

Dolek B., Eraslan S., Eroglu S., Kesim B. E., Ulutin T., Yalginer A., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.13, no.4, pp.435-438, 2007 (SCI-Expanded, Scopus)

50. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease

ULUTİN T.

Clin Appl Thromb Hemost. , vol.13, no.3, pp.308-312, 2007 (SCI-Expanded)

51. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease

Butun I. I., Ekmekci H., Sonmez H., Gurel C., Ciftci O., Ulutin T., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.13, no.3, pp.308-312, 2007 (SCI-Expanded, Scopus)

52. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency

Güven M., Sağcı Güven G., Öz E., Özaydın A., Batar B., Ulutin T., et al.

Heart And Vessels , vol.22, no.6, pp.355-360, 2007 (SCI-Expanded, Scopus)

53. Individual sensitivity to cytogenetic effects of benzo[alpha]pyrene in cultured human lymphocytes: Influence of glutathione S-transferase M1 genotype

Guven G., Guven M., Onaran H., Ulutin T., Hacianefioglu S.

GENETICS AND MOLECULAR BIOLOGY , vol.29, no.1, pp.142-147, 2006 (SCI-Expanded, Scopus)

54. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.

ULUTİN T.

Thromb Res. , vol.117, no.3, pp.249-254, 2006 (SCI-Expanded)

55. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.

ULUTİN T.

Clin Nephrol. , vol.65, no.2, pp.97-102, 2006 (SCI-Expanded)

56. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation

Cetin O., Bekpinar S., Unlucerci Y., Turkmen A., Bayram Ç., Ulutin T.

CLINICAL NEPHROLOGY , vol.65, pp.97-102, 2006 (SCI-Expanded, Scopus) Sustainable Development

57. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease

Ekmekci H., Isler I., Sonmez H., Gurel C., Ciftci O., Ulutin T., et al.

THROMBOSIS RESEARCH , vol.117, no.3, pp.249-254, 2006 (SCI-Expanded, Scopus)

58. Factor v Leiden mutation in cerebrovascular disease

BUYRU N., Altinisik J., SOMAY G., ULUTIN T.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.11, no.3, pp.339-342, 2005 (SCI-Expanded, Scopus) Sustainable Development

59. Factor V Leiden mutation in cerebrovascular disease

ULUTİN T.

Clin Appl Thromb Hemost. , vol.11, no.3, pp.339-342, 2005 (SCI-Expanded)

60. Platelet function and fibrinolytic activity in patients with bronchial asthma.

ULUTİN T.

Clin Appl Thromb Hemost. , vol.11, no.3, pp.77-81, 2005 (SCI-Expanded)

61. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.

ULUTİN T.

Clin Biochem. , vol.38, no.1, pp.92-96, 2005 (SCI-Expanded)

62. The effect of glutathione S-transferase M1 genotype on benzo[α] pyrene-induced sister chromatid exchanges and chromosomal aberrations in peripheral blood lymphocytes

Güven G. S., Güven M., Onaran İ., Ulutin T., Hacihanefioǧlu S.

Turkish Journal of Medical Sciences , vol.35, no.2, pp.79-84, 2005 (SCI-Expanded, Scopus, TRDizin)

63. Enhanced sensitivity to oxidant-induced micronucleus frequency in elderly individuals is not associated with glutathione S-transferase M1 (GSTM1) null genotype in lymphocytes.

ULUTİN T.

GERONTOLOGY , vol.51, no.1, pp.29-33, 2005 (SCI-Expanded, Scopus)

64. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease

Bilgen D., Sonmez H. A., Ekmekci H., Ulutin T., Ozturk Z. B., Kökoğlu E., et al.

CLINICAL BIOCHEMISTRY , no.1, pp.92-96, 2005 (SCI-Expanded, Scopus) Sustainable Development

65. Enhanced sensitivity to oxidant-induced micronucleus frequency in elderly individuals is not associated with glutathione S-transferase M1(GSTM1) null genotype in lymphocytes

Guven G., Guven M., Onaran I., Tunckale A., Hacihanefioglu S., Ulutin T.

GERONTOLOGY , vol.51, no.1, pp.29-33, 2005 (SCI-Expanded, Scopus)

66. Enhanced sensitivity to oxidant-induced micronucleus frequency in elderly individuals is not associated with GSTM1 null genotype in lymphocytes

SAĞCI GÜVEN G., GÜVEN M., ONARAN İ., TUNÇKALE A., HACIHANEFİOĞLU S., ULUTİN T.

GERONTOLOGY , vol.51, pp.29-33, 2005 (SCI-Expanded, Scopus)

67. Platelet function and fibrinolytic activity in patients with bronchial asthma

Tutluoglu B., Gurel Ç., Ozdas S., Musellim B., Erturan S., Anakkaya A., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.11, pp.77-81, 2005 (SCI-Expanded, Scopus)

68. Effects of Atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease

TEKIN A., TEKIN G., GUZELSOY D., Kaya A., GUREL C., YIGIT Z., et al.

AMERICAN JOURNAL OF CARDIOLOGY , vol.94, no.2, pp.206-209, 2004 (SCI-Expanded, Scopus)

69. In vivo effect of losartan on platelet aggregation in patients with hypertension

Akdemir R., Ozhan H., Yazici M., Gunduz H., Duran S., Gurel Ç., et al.

HEART AND VESSELS , vol.19, no.4, pp.167-171, 2004 (SCI-Expanded, Scopus)

70. In vivo effect of losartan on platelet aggregation in patients with hypertension.

ULUTİN T.

Heart Vessels. , vol.19, no.4, pp.167-171, 2004 (SCI-Expanded)

71. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease

ULUTİN T.

Am J Cardiol. , vol.94, no.2, pp.206-209, 2004 (SCI-Expanded)

72. GSTT1 Null Genotipinde Eritrosit Glutatyon Konjugat Transportu

Özaydın A., Onaran İ., Ulutin T.

Kocatepe Tıp Dergisi , vol.4, pp.59-62, 2003 (TRDizin)

73. PCR-RFLP detection of PAI-2 variants in myocardial infarction

BUYRU N., Altinisik J., GUREL C., ULUTIN T.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.9, no.4, pp.333-336, 2003 (SCI-Expanded, Scopus)

74. Looking for Our Ten Years Results for Coronary Heart Disease and Ischemic Stroke Group for the Standpoint of Haemostasis

Ulutin T., Sönmez H. A., İnce F. B., Nergis ., Bayram Gürel Ç., Dilek U., et al.

Turkish Journal Of Hematology , vol.19, no.2, pp.255-263, 2002 (SCI-Expanded, Scopus, TRDizin)

75. Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia

ULUTİN T.

Haematologia (Budap). , vol.32, no.4, pp.475-482, 2002 (SCI-Expanded)

76. Looking for our ten years results for coronary heart disease and ischemic stroke group for the standpoint of haemostasis

Ulutin T., Sönmez H. A., Domaniç N., İnce B., Bayram G., Ural D., et al.

Turkish Journal of Haematology , vol.19, no.2, pp.255-263, 2002 (SCI-Expanded, Scopus, TRDizin)

77. Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia

Arısal Ö., Deviren A., Fenerci E., Hacıhanefioğlu S., Ulutin T., Erkmen S., et al.

HAEMATOLOGIA , vol.32, no.4, pp.475-482, 2002 (SCI-Expanded, Scopus) Sustainable Development

78. Screening of Factor V Leiden (G1691A), prothrombin G20210A and protein C gene mutations in thrombosis patients.

ULUTIN T., Altinisik J., ATES H. N., CENGIZ M., SAYHAN N.

AMERICAN JOURNAL OF HUMAN GENETICS , vol.69, no.4, pp.430, 2001 (SCI-Expanded, Scopus)

79. Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies

ULUTİN T.

J Child Neurol. , vol.16, no.8, pp.603-606, 2001 (SCI-Expanded)

80. Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: Two-year prospective studies

Yuksel A., Cengiz M., Seven M., Ulutin T.

JOURNAL OF CHILD NEUROLOGY , vol.16, pp.603-606, 2001 (SCI-Expanded, Scopus)

81. The influence of GSTM1 null genotype on susceptibility to in vitro oxidative stress.

ULUTİN T.

TOXICOLOGY , vol.157, no.3, pp.195-205, 2001 (SCI-Expanded, Scopus)

82. Effect of acute hyperglycemia on potassium (Rb-86(+)) permeability and plasma lipid peroxidation in subjects with normal glucose tolerance

Guven M., Onaran I., Ulutin T., Sultuybek G., Hatemi H.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.24, no.4, pp.231-235, 2001 (SCI-Expanded, Scopus)

83. Factor VII levels in patients undergoing coronary angiography: Factor VII and coronary artery disease

Domanic N., Ural D., Vural V., Gurel Ç., Ulutin T.

JOURNAL OF CARDIOVASCULAR RISK , vol.8, no.2, pp.57-61, 2001 (SCI-Expanded, Scopus)

84. Factor VII levels in patients undergoing coronary angiography: factor VII and coronary artery disease.

ULUTİN T.

J Cardiovasc Risk. , vol.8, no.2, pp.57-61, 2001 (SCI-Expanded)

85. The influence of GSTM1 null genotype on susceptibility to in vitro oxidative stress

Onaran I., Guven G., Ozaydin A., Ulutin T.

TOXICOLOGY , vol.157, pp.195-205, 2001 (SCI-Expanded, Scopus)

86. Effect of acute hyperglycemia on potassium (86Rb+) permeability and plasma lipid peroxidation in subjects with normal glucose tolerance

GÜVEN M., ONARAN İ., ULUTİN T., KANIGÜR G., Hatemi H.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.24, no.1, pp.231-235, 2001 (SCI-Expanded, Scopus)

87. Effect of acute hyperglycemia on potassium (86Rb+) permeability and plasma lipid peroxidation in subjects with normal glucose tolerance

Güven M., Onaran I., Ulutin T., Sultuybek G., Hatemi H.

Journal of Endocrinological Investigation , vol.24, no.4, pp.231-235, 2001 (SCI-Expanded, Scopus)

88. The effect of agmatine on the platelet aggregation in streptozotocin diabetic rats

Bicakci B., Ulutin T., Bayram Ç., Ozyazgan S., Akkan A.

DIABETOLOGIA , vol.43, 2000 (SCI-Expanded, Scopus) Sustainable Development

89. The effect or agmatine on the responses of isolated thoracic aorta in streptozotocin diabetic rats

Akkan A. G., Ozyazgan S., Bicakci B., Barutcu B., Ozturk M., Kaya F., et al.

DIABETOLOGIA , vol.43, 2000 (SCI-Expanded, Scopus) Sustainable Development

90. Carbohydrate-deficient transferrin and sialidase levels in coronary heart disease

Sonmez H. A., Ozturk Z. B., Ulutin T., Domanic N., Kokoglu E. H.

THROMBOSIS RESEARCH , vol.99, no.4, pp.311-315, 2000 (SCI-Expanded, Scopus)

91. Carbohydrate-deficient transferrin and sialidase levels in coronary heart disease.

ULUTİN T.

Thromb Res. , vol.99, no.4, pp.311-315, 2000 (SCI-Expanded)

92. Are individuals with glutathione S-transferase GSTT1 null genotype more susceptible to in vitro oxidative damage?

ULUTİN T.

J Toxicol Environ Health A. , vol.59, no.1, pp.15-26, 2000 (SCI-Expanded)

93. Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy

ULUTİN T.

J Basic Clin Physiol Pharmacol. , vol.11, no.1, pp.73-81, 2000 (SCI-Expanded)

94. Inhibition of platelet function by GSTM1-null human peripheral lymphocytes exposed to benzo(a)pyrene-induced challenge.

ULUTİN T.

Cell Biol Toxicol. , vol.16, no.5, pp.313-323, 2000 (SCI-Expanded)

95. . Erythrocyte Glutathione, Glutathione Peroxidase, Superoxide Dismutase and Serum Lipid Peroxidation in Epileptic Children With Valproate And Carbamazepine Monotherapy

Yüksel A., CENGİZ M., SEVEN M., ULUTİN T.

J Basic Clin Physiol Pharmacol , vol.11, no.1, pp.73-81, 2000 (Scopus)

96. Are individuals with glutathione S-transferase GSTT1 null genotype more susceptible to in vitro oxidative damage?

Onaran I., Ozaydin A., Akbas F., Gultepe M., Tunckale A., Ulutin T.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES , vol.59, no.1, pp.15-26, 2000 (SCI-Expanded, Scopus) Sustainable Development

97. Inhibition of platelet function by GSTM1-null human peripheral lymphocytes exposed to benzo(a)pyrene-induced challenge

Onaran I., Ozaydin A., Ozdas S., Ulutin T.

CELL BIOLOGY AND TOXICOLOGY , vol.16, no.5, pp.313-323, 2000 (SCI-Expanded, Scopus) Sustainable Development

98. Erythrocyte Glutathione, Glutathione Peroxidase, Superoxide Dismutase And Serum Lipid Peroxidation In Epileptic Children With Valproate And Carbamazepine Monotherapy

Yüksel A., Cengiz M., Seven M., Ulutin T.

Journal of Basic and Clinical Physiology and Pharmacology , vol.11, no.1, pp.73-81, 2000 (Scopus)

99. Hemostatic markers in ischemic stroke of undetermined etiology

Ince B., Bayram Ç., Harmanci P., Ulutin T.

THROMBOSIS RESEARCH , vol.96, no.3, pp.169-174, 1999 (SCI-Expanded, Scopus)

100. Hemostatic markers in ischemic stroke of undetermined etiology.

ULUTİN T.

Thromb Res. , vol.93, no.3, pp.169-174, 1999 (SCI-Expanded)

101. Toxic effect of ethanol upon antioxidant defens system and immunological parameters in the various tissues of the young rats which are 10 and 30 days old.

AKYOL S., İNCE E., ULUTİN A. N. T., TUNALI H.

Journal of Medical Faculty, Osmangazi University, Special Issue for Free Radicals and Antioxidans. , vol.1, pp.211-226, 1999 (Peer-Reviewed Journal)

102. Relationship between levels of fibronectin and of platelet aggregation in coronary heart disease

Domanic N., Ulutin T., Sonmez H. A., Ozturk Z. B., Bayram Ç., Turgut M., et al.

ATHEROSCLEROSIS , vol.146, 1999 (SCI-Expanded, Scopus)

103. Age-related changes on glucose transport and utilization of human erythrocytes: effect of oxidative stress.

ULUTİN T., KANIGÜR G., GÜVEN M.

GERONTOLOGY , vol.45, no.2, pp.79-82, 1999 (SCI-Expanded, Scopus)

104. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis

ULUTİN T.

Cancer Biochem Biophys. , vol.17, no.1, pp.155-162, 1999 (SCI-Expanded) Sustainable Development

105. Two female siblings with a previously unreported MCA/MR syndrome: pre- and postnatal growth retardation, iris colobomata, spasticity, facial dysmorphism and dilated ventricles

ULUTİN T.

Genet Couns. 1999 , vol.10, no.3, pp.265-269, 1999 (SCI-Expanded)

106. Age-related changes on glucose transport and utilization of human erythrocytes: Effect of oxidative stress

Guven M., Ozkilic A., Kanigur-Sultuybek G., Ulutin T.

GERONTOLOGY , vol.45, no.2, pp.79-82, 1999 (SCI-Expanded, Scopus) Sustainable Development

107. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis” Cancer Biochemistry Biophysics

GÜVEN M., Öztürk B., Sayal A., Özet A., ULUTİN T.

CANCER BIOCHEMISTRY BIOPHYSICS , vol.17, no.1, pp.155-162, 1999 (SCI-Expanded) Sustainable Development

108. Two female siblings with a previously unreported MCA/MR syndrome: Pre and postnatal growth retardation, iris colobomata, spasticity, facial dysmorphism and dilated ventricles

Yuksel A., Seven M., Deviren A., Soylemez M., Hacihanefioglu S., Ulutin T., et al.

GENETIC COUNSELING , vol.10, no.3, pp.265-269, 1999 (SCI-Expanded, Scopus)

109. The modulation of glucocorticoid receptor content by 3-O-methyl-D-glucose transport in human mononuclear leukocyte in obesity

Guven M., Hatemi H., Tasan E., Altuntaş Y., Ulutin T., Tezcan V., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.21, no.10, pp.656-661, 1998 (SCI-Expanded, Scopus) Sustainable Development

110. The modulation of glucocorticoid receptor content by 3-O-methyl-D-glucose transport in human mononuclear leukocyte in obesity.

ULUTİN T.

J Endocrinol Invest. , vol.21, no.10, pp.656-661, 1998 (SCI-Expanded) Sustainable Development

111. The relationship of various factors in the pathogenesis of atherosclerosis

Sonmez H. A., Suer S., Ulutin T., Kokoglu E. H., Ucisik N.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.4, no.2, pp.105-110, 1998 (SCI-Expanded, Scopus)

112. The molecular markers of hemostatic activation on coronary artery disease

ULUTİN T.

Thromb Res. , vol.88, no.3, pp.329-332, 1997 (SCI-Expanded)

113. The molecular markers of hemostatic activation on coronary artery disease

Ulutin T., Sonmez H. A., Ucisik N., Suer S., Bayram Ç., Kokoglu E. H., et al.

THROMBOSIS RESEARCH , vol.88, no.3, pp.329-332, 1997 (SCI-Expanded, Scopus)

114. The importance of Lp(a)-fibronectin interaction in atherogenesis.

ULUTİN T.

Haematologia (Budap). , vol.28, no.3, pp.149-153, 1997 (SCI-Expanded)

115. The interaction between foam cell formation and fibrinolysis in the atherogenesis

Sonmez H. A., Ulutin T., Suer S., Kokoglu E., Bayram Ç., Sultuybek G., et al.

THROMBOSIS AND HAEMOSTASIS , 1997 (SCI-Expanded, Scopus)

116. The importance of Lp(a)-fibronectin interaction in atherogenesis

Sonmez H. A., Suer S., Kokoglu E., Dirican A., Ulutin T., Ucisik N., et al.

HAEMATOLOGIA , vol.28, no.3, pp.149-153, 1997 (SCI-Expanded)

117. Carbohydrate-deficient transferrin and sialidase levels in coronary heart disease

ULUTİN A. N. T., Sonmez H. A., GÜNGÖR Z. B., Kokoglu E., ULUTİN A. N. T., Sozer V., et al.

BLOOD , vol.88, no.10, pp.2958, 1996 (SCI-Expanded, Scopus)

118. Plasma Lp(a) and t-PA-PAI-1 complex levels in coronary heart disease

Suer S., Ulutin T., Sonmez H. A., Kokoglu E. H., Ucisik N., Bayram Ç., et al.

THROMBOSIS RESEARCH , vol.83, no.1, pp.77-85, 1996 (SCI-Expanded, Scopus)

119. Effect of defibrotide on platelet function.

ULUTİN T.

Semin Thromb Hemost. , vol.22, pp.4-5, 1996 (SCI-Expanded)

120. Effect of defibrotide on platelet function

Ulutin O., BalkuvUlutin S., BezerGoker B., Cizmeci G., Ferhanoglu B., Ozsoy Y., et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS , vol.22, pp.21-24, 1996 (SCI-Expanded, Scopus)

121. The effect of endothelin-1 on vena jugularis thrombus model in rabbits

ULUTİN T.

J Basic Clin Physiol Pharmacol. , vol.6, no.3, pp.295-302, 1995 (SCI-Expanded)

122. The effect of endothelin-1 on vena jugularis thrombus model in rabbits

ULUTİN A. N. T., GÜREL Ç., Okar I., Özlük K., TÖZÜN A. N., Ulutin O. N.

Journal of Basic and Clinical Physiology and Pharmacology , vol.6, no.3-4, pp.295-302, 1995 (Scopus)

123. Synergistic effect of butyrate on platelet responses to arachidonate

Ulutin T., Kanigur-Sultuybek G., Cenani A.

Klinik Gelisim , vol.6, no.11, pp.2748-2751, 1993 (Scopus)

124. THE INFLUENCE OF SULFHYDRYL-GROUP AGENTS ON INSULIN-RECEPTORS AND GLUCOSE TRANSPORTERS IN GERIATRIC GROUPS

SULTUYBEK K., TEZCAN V., GUVEN M., ONARAN I., ULUTIN T., ULUTIN O.

THROMBOSIS AND HAEMOSTASIS , vol.69, no.6, pp.807, 1993 (SCI-Expanded, Scopus)

125. The effect of metformin and gliclazide on platelets and red blood cell glucose transport mechanisms in impaired glucose tolerance and type II diabetic patients with vasculopathy

KANIGÜR G., Hatemi H., GÜVEN M., ULUTİN T., Tezcan V., Ulutin O.

Thromb Haemorrh Disorders , vol.7, no.1, pp.17-21, 1993 (SCI-Expanded) Sustainable Development

126. The levels of protein C, S in term and preterm newborns and their response to the vitamin K administration

Altinkaya N., Sever L., Ozsoy Y., Ulutin T., Arvas A., Ulutin O., et al.

Cerrahpasa Tip Fakultesi Dergisi , vol.23, no.2, pp.195-201, 1992 (Scopus)

127. The pharmacology and clinical pharmacology of defibrotide: A new profibrinolytic, antithrombotic and anti-platelet substance

Ulutin O., Balkuv-Ulutin S., Ugur M., Ulutin T., Ozsoy Y., Cizmeci G.

Advances in Experimental Medicine and Biology , vol.281, pp.429-438, 1991 (SCI-Expanded, Scopus)

128. The pharmacology and clinical pharmacology of defibrotide: a new profibrinolytic, antithrombotic and anti-platelet substance.

ULUTİN T.

Adv Exp Med Biol. , vol.281, pp.429-438, 1990 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 49

1. Vitamin-D combined with resveratrol regulates islets hemostasis, β-cell regeneration, ER-stress and inflammation in fructose-fed diet/STZ-induced diabetic rats.

Dağıstanlı F., Akdemir A. S., Aykaç M., Aydemir D., Tanrıverdi G., Ulutin A. N. T., et al.

16th Multinational Congress on Microscopy, Brno, Czech Republic, 4 - 06 September 2022, pp.255-256, (Full Text) Sustainable Development

2. COMBINATION OF RESVERATROL WITH VITAMIN D AMELIORATES HEPATIC TISSUE DAMAGES, OXIDATIVE/ER STRESSES AND INFLAMMATION IN HIGHFRUCTOSE/LOW-STREPTOZOTOCIN INDUCED DIABETIC RATS

Dağıstanlı F., Aykaç M., Uysal Ö., Tanrıverdi G., Ulusu N., Ulutin A. N. T., et al.

ICSD2022"Future of Cell Death in Basic Science and Translational Medicine", İstanbul, Turkey, 2 - 04 July 2022, pp.75, (Summary Text) Sustainable Development

3. Alzheimer Hastalığında mir24-3p ve mir26-5p Ekspresyon Düzeylerinin Endotel ve Trombosit Fonksiyonları Üzerine olan Etkisinin İncelenmesi

Ayaz G., Sordu P., Alaylıoğlu M., Samancı B., Bilgiç B., Hanağası H. A., et al.

XVIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, İstanbul, Turkey, 28 - 31 October 2021, vol.52, pp.78-79, (Summary Text)

4. ‘’Investigation of the Molecular Mechanism of Endothelial Dysfunction and ADP-Induced Platelet Aggregation in Alzheimer's Disease’’

Ayaz G., Sordu P., Alaylıoğlu M., Samancı B., Bilgiç B., Hanağası H. A., et al.

8th International Congress of Molecular Medicine , İstanbul, Turkey, 9 - 12 November 2021, pp.15, (Summary Text)

5. Düşük kardiyovasküler riskli kişilerde endotel disfonksiyon belirleyicileri: Erkeklerin ve kadınların karşılaştırılması.

Güngör Z. B., Sipahioğlu N., Sönmez H. A., Ekmekçi H., Toprak S., Ayaz G., et al.

4.Aterometabolik ve Renal Hastalıklar E Sempozyumu / Aterometre 2021, İstanbul, Turkey, 5 - 07 March 2021, no.4, pp.13, (Summary Text)

6. The protective effects of Vit D on pancreatic islet cell in high fructose-low STZ induced diabetes

Dağıstanlı F., Akdemir A. S., Anapalı M., Ulutin A. N. T., Öztürk Sezgin M.

Virtual Early Career European Microscopy Congress 2020, Kobenhavn, Denmark, 24 - 25 November 2020, pp.54-55, (Summary Text) Sustainable Development

7. Yuksek Fruktoz-Düşük Streptozotocin Diyabet Modelinde Resveratrol’ün Pankreas Adacik Hücreleri üzerindeki Etkileri

Dağıstanlı F., Akademir A. S., Anapalı M., Ulutin A. N. T., Öztürk M.

16. Ulusal Tibbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2019, pp.1-2, (Summary Text) Sustainable Development

8. Metformin, Meme Kanseri Hücrelerinin Metastaz Ve İnvazyonu Üzerindeki Anti-Kanser Etkisini NF-kB'yi Düzenleyerek Gösterir.

Yenmiş G., Şenol K., Beşli N., Yaprak Saraç E., Soydaş T., TUNÇDEMİR M., et al.

16.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 26 - 30 October 2019, pp.64, (Summary Text) Sustainable Development

9. Resveratrol recovers beta cell mass, islet morphology and apoptosis in fructose-fed streptozotocin induced rodent diabetes

Dağıstanlı F., Akdemir S., Anapalı M., Ulutin A. N. T., Öztürk Sezgin M.

14th Multinational Congress on Microscopy, Belgrade, Serbia, 15 - 20 September 2019, pp.1-3, (Full Text) Sustainable Development

10. Expression of SLC22A23 gene in laryngeal carcinoma

BUYRU N., EKIZOGLU S., Karaman E., Ulutin T.

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, Kiribati, 1 - 05 April 2017, vol.77, (Summary Text)

11. Efects of constant magnetic field of platelet function.

Gürel Ç., Ayaz G., Tuncel H., Kalkan T., Kurşun N., Ulutin A. N. T.

15th International Congress of Histochemistry and Cytochemistry (ICHC), Antalya, Turkey, 18 - 21 May 2017, vol.10.5505, no.5505, pp.235, (Full Text)

12. Expression of miR-1252 and its target PRR4 gene in laryngeal carcinoma

BUYRU N., EKIZOGLU S., Guliyev J., Karaman E., Ulutin T.

AACR 107th Annual Meeting on Bioinformatics and Systems Biology, Louisiana, United States Of America, 16 - 20 April 2016, vol.76, (Summary Text)

13. Periferik arter Hastalığı Etiyolojisinde ADAMTS7 Ekspresyonu ve rs1994016 ve rs3825807 Varyantlarının Araştırılması

BAYOĞLU B., ARSLAN C., TEL ÜSTÜNIŞIK Ç., ULUTİN A. N. T., CENGİZ M.

Ulusal Moleküler Tıp Sempozyumu, İstanbul, Turkey, 1 - 03 June 2016, pp.70, (Full Text)

14. INCREASED PLATELET ACTIVATION AND P-SELECTIN IN OBSTRUCTIVE SLEEP APNEA SYNDROME

Bayram-Gurel C., Korkmaz E., Adin-Cinar S., Ayaz G., Kanigur G., Deniz G., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Turkey, 4 - 07 May 2016, vol.141, (Summary Text)

15. ASSOCIATION OF MDR1 C3435T AND G2677T/A POLYMORPHISMS WITH PLASMA PLATELET ACTIVATING FACTOR LEVELS AND ADP-INDUCED PLATELET FUNCTIONS IN CORONARY ARTERY DISEASE PATIENTS

Ulutin T., AYAZ G. E., Batar B., Kanigur G., Guven M., Onaran İ., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Turkey, 4 - 07 May 2016, vol.141, (Summary Text)

16. Relationship between adipocytokines, angiogenesis-related factors and ADP-induced platelet aggregation in patients with preeclampsia

Ekmekci O. B., Ekmekci H., Öztürk Z., Tuten A., Toprak M. A., Korkmaz M. S., et al.

FEBS EMBO 2014 Conference, Paris, France, 30 August - 04 September 2014, vol.281, pp.535-536, (Summary Text)

17. INVESTIGATING THE CORRELATION BETWEEN PLASMA PLATELET ACTIVATING FACTOR LEVELS AND MDR1 C3435T AND G2677T/A POLYMORPHISMS IN CORONARY ARTERY DISEASE PATIENTS

Ulutin T., Ayaz G., Batar B., Kanigur G., Guven M., Onaran I., et al.

23rd MLTD Biennial International Congress on Thrombosis, Valencia, Spain, 14 - 17 May 2014, vol.133, (Summary Text)

18. Genetik uzmanı gözü ile venöz tromboembolizm risk değerlendirmesi

ULUTİN A. N. T.

8.Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, İstanbul, Turkey, 17 - 19 April 2014, pp.8, (Summary Text)

19. The effect of vitamin D treatment on GLIA derived neurotrophic factor in cortical neurons

Yilmazer S., Ulutin T., Dursun E., Gezen-Ak D.

16th Annual Conference of the International-Society-for-Bipolar-Disorders, Seoul, South Korea, 18 - 21 March 2014, vol.16, pp.87-88, (Summary Text)

20. Geçmişden geleceğe genetik

ULUTİN A. N. T.

XI.IUGEN International Molecular Biology Students winter school, İstanbul, Turkey, 11 - 13 February 2014, pp.5-15, (Full Text)

21. Association of MDR-1 gene polymorphism and plasma platelet activating factor levels in patients with coronary artery disease

Ulutin T., Ayaz G., Karadag B., Kanigur G., Guven M., Onaran I., et al.

22nd International Congress on Thrombosis, Nice, France, 6 - 09 October 2012, vol.130, (Summary Text)

22. The effect of vitamin D receptor gene silencing on L type calcium channels alpha 1 C in hippocampal neurons

ULUTİN T., YILMAZER S., DURSUN E., GEZEN AK D.

14th International Congress of Histochemistry and Cytochemistry (ICHC 2012), Japan, vol.P3-46, pp.153, (Summary Text)

23. Meme Kanserli Hastalarda WWOX Geninin Araştırılması.

EKİZOĞLU ERATAK S., ULUTİN A. N. T., BUYRU A. N.

XII. Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 27 - 30 October 2011, (Full Text) Sustainable Development

24. Complement system activation and antioxidant system changes in pregnant rats’ offspring treated with gavage ethanol.

AKYOL S., İNCE E., ULUTİN A. N. T., TUNALI H.

FEPS and Turkish Physiological Society Scientific Congress 2011, İstanbul, Turkey, 3 - 07 September 2011, pp.76, (Full Text)

25. Using SELDI-TOF MS to Identify Serum Biomarkers in NSCLC.

BAYKARA O., BUYRU A. N., ULUTİN A. N. T., DALAY M. N.

4th AACR International Conference . Molecular Diagnostics in Cancer Therapeutic Development. Challenges and New Horizons, Denver, United States Of America, 27 - 30 September 2010, vol.16, no.19, pp.23, (Full Text)

26. Genetic alterations of the LKB1 gene in head and neck cancer

EKİZOĞLU ERATAK S., KENANLI E., KARAMAN E., ENVER Ö., ULUTİN A. N. T., BUYRU A. N.

21th Meeting of the European Association for Cancer Research, Oslo, Norway, 26 - 29 June 2010, (Full Text) Sustainable Development

27. Genetic alterations of the LKB1 gene in head and neck cancer

Ekizoglu S., Kenanli E., Karaman E., Enver O., Ulutin T., Buyru N.

21st Meeting of the European-Association-for-Cancer-Research, Oslo, Norway, 26 - 29 June 2010, vol.8, pp.178, (Summary Text) Sustainable Development

28. Methylation status of the LOT1 gene in breast cancer

BUYRU A. N., ULUTİN A. N. T., EKİZOĞLU ERATAK S.

AACR-JCA Joint conference:Cancer Genomics, Epigenomics and the development of N0vel Therapeutics, 5 - 09 February 2010, pp.1-3, (Full Text) Sustainable Development

29. CYTOTOXICITY BY COMBINED TREATMENT OF WARFARIN AND DOXORUBICIN ON LEUKEMIC CELLS IN VITRO

Ulutin T.

14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.498-499, (Summary Text)

30. Meme Kanserli Hastalarda LOT1 Geninin Metillenerek Sessizleşmesi

EKİZOĞLU ERATAK S., ULUTİN A. N. T., BUYRU A. N., TURGUT H.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, (Full Text) Sustainable Development

31. Investigation of the EMSY gene and protein in patients with ovarian

Buyru N., Altinisik J., Ulutin T.

20th Meeting of the European-Association-for-Cancer-Research, Lyon, France, 5 - 08 July 2008, vol.6, pp.148, (Summary Text)

32. ESTROGEN RECEPTOR I GENE POLYMORPHISMS AND CORONARY ARTERY DISEASE IN THE TURKISH POPULATION

Ulutin T. U., Guven M., Oz E., Batar B., Karadag B., Domanic N.

13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.552, (Summary Text)

33. Relationship Between Homocysteine, Adiponectin and ADP-Induced Platelet Aggregation Levels in Untreated Essential Hypertension.

BALCI EKMEKÇİ Ö., EKMEKÇİ H., Erdine S., Ataev Y., ÖZTÜRK Z. B., Butun I. I., et al.

Fifth Mediterranean Meeting on Hypertension and Atherosclerosis, İzmir, Turkey, 23 - 27 April 2008, (Full Text)

34. DNA Repair Gene XRCC1 and XPD Polymorphisms and Theır Assocıatıon Wıth Coronary Artery Dısease Risks and Mıcronucleus Frequency

Güven M., Özaydın A., Batar B., Ulutin A. N. T.

XXIst Congress of International Society on Thrombosis and Haemostasis, Geneve, Switzerland, 6 - 12 July 2007, pp.391, (Full Text)

35. High dose warfarin inhibits cell proliferation and induces apoptosis in leukaemia K562 and HL-60 cells

Ulutin T., Onaran I., Sencan S., Demirtas H., Aydemir B.

4th International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, Italy, 26 - 28 October 2007, vol.120, (Summary Text)

36. VDBP Gene Polymorphism in COPD

BAYKARA O., Soyyiğit Ş., BUYRU A. N., ULUTİN A. N. T., Erk M.

15th European Respiratory Society Congress, Kopenhag, Denmark, 17 - 21 September 2005, pp.53, (Full Text)

37. KOAH'LI hastalarda vitamin D binding protein (VDBP) gen varyantlarının araştırılması

Soyyiğit Ş., BAYKARA O., BUYRU A. N., ULUTİN A. N. T., Erk M.

Toraks Derneği 8. Yıllık Kongre, Antalya, Turkey, 27 April - 01 May 2005, (Full Text)

38. Akciğer kanserli hastalarda vitamin D bağlayan protein (VDBP) gen polimorfizmi

BAYKARA O., ULUTİN A. N. T., Mihmanlı A., BUYRU A. N.

XV. Ulusal Kanser Kongresi., Antalya, Turkey, 20 - 24 April 2005, pp.123, (Full Text) Sustainable Development

39. Platelet Fibronectin, Sialic acid and Aggregation Levels in Coronary Heart Disease.

Bütün İ., Ciftci O., EKMEKÇİ H., SÖNMEZ H. A., GÜREL Ç., ULUTİN T., et al.

I. Ulusal Moleküler Tıp Kongresi, İstanbul, Turkey, 16 - 19 April 2005, (Full Text)

40. Evaluation of nitric oxide, platelet fibronectin and platelet aggregation levels in coronary heart disease

Butun I., Domanic N., Ekmekci H., Sonmez H. A., Ciftici O., Gurel B., et al.

75th Congress of the European-Atherosclerosis-Society, Prague, Czech Republic, 23 - 26 April 2005, vol.6, pp.13-14, (Summary Text)

41. Beyin travması ve kafa yaralanması geçiren hastalarda Apolipoprotein E gen polimorfizmlerinin incelenmesi

BAYKARA O., BUYRU A. N., ULUTİN A. N. T.

8. Ulusal Tıbbi Biyoloji Kongresi,, Adana, Turkey, 14 - 17 October 2003, pp.101, (Full Text)

42. Are hepatitis B virus carriers at risk of coronary atherosclerosis?

Domanic N., Akyn P., Vural V., Balcy H., Avsar S., Ipekci S., et al.

13th International Symposium on Atherosclerosis, Kyoto, Japan, 28 September - 02 October 2003, vol.4, pp.28, (Summary Text) Sustainable Development

43. Plasma TFPI and Lp (a) levels in coronary heart disease.

DOMANİÇ N., Bilgen D., SÖNMEZ H. A., GÜREL Ç., EKMEKÇİ H., ÖZTÜRK Z. B., et al.

European Atherosclerosis Society 73nd EAS Congress, Salzburg, Austria, 7 - 10 July 2002, pp.26, (Full Text)

44. Plasma TFPI and PAI-I levles in coronary heart disease.

DOMANİÇ N., Bilgen D., ÖZTÜRK Z. B., EKMEKÇİ H., SÖNMEZ H. A., ULUTİN T., et al.

Turkish-Italian-Spanish Joint Meeting on Hypertension and Atherosclerosis., Antalya, Turkey, 11 - 16 June 2002, pp.27, (Full Text)

45. Evaluation of relation between glaucoma and antioxidative system (GST-M and GST-T) polymorphisms

Ozkilic A., Guven M., Unal M., Devranoglu K., Ulutin T.

European-Society-of-Human-Genetics European Human Genetics Conference in Conjuction With European Meeting on Psychosocial Aspects of Genetics, Strasbourg, France, 25 - 28 May 2002, vol.10, pp.287, (Summary Text)

46. Trombosit agregasyonu ve fibronektin düzeyleri arasındaki ilişkinin koroner kalp hastalarında incelenmesi.

SÖNMEZ H. A., ULUTİN T., ÖZTÜRK Z. B., EKMEKÇİ H., Bayram Ç., KÖKOĞLU E., et al.

The First International Biosciences days, Antalya, Turkey, 20 - 24 April 1999, pp.24, (Full Text)

47. The relationship between levels of fibronectin and of platelet aggregation in coronary heart disease.

DOMANİÇ N., ULUTİN T., SÖNMEZ H. A., ÖZTÜRK Z. B., Bayram Ç., Turgut M., et al.

The First International Sciences Days., Antalya, Turkey, 20 - 24 April 1999, pp.19, (Full Text)

48. Antiepileptik ilaç kullanımının Glutatyon, Glutatyon peroksidaz, Süperoksit dismutaz ve Lipid peroksidasyonuna etkisi

YÜKSEL A., CENGİZ M., Seven M., ULUTİN T., Cenani A.

4. Çocuk Nörolojisi Günleri Program Kitabı, İstanbul, Turkey, 11 - 14 November 1998, pp.17, (Full Text)

49. THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF DEFIBROTIDE - A NEW PROFIBRINOLYTIC, ANTITHROMBOTIC AND ANTIPLATETLET SUBSTANCE

ULUTİN A. N. T., BALKUVULUTIN S., UGUR M., ULUTİN A. N. T., OZSOY Y., CIZMECI G.

INTERNATIONAL SCIENTIFIC SYMP ON FIBRINOGEN, THROMBOSIS, COAGULATION, AND FIBRINOLYSIS, Taipei, Taiwan, 30 August - 01 September 1989, vol.281, pp.429-438, (Full Text)

Books 12